Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents

Producing human mesenchymal stromal cells (MSCs) for clinical use requires adherence to current good manufacturing practice (cGMP) standards. This is necessary for ensuring standardization and reproducibility through the manufacturing process, but also, for product quality and safety. However, the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz-Nogués, Clara, O'Brien, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934414/
https://www.ncbi.nlm.nih.gov/pubmed/36824657
http://dx.doi.org/10.1016/j.bbiosy.2021.100018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934414/
https://www.ncbi.nlm.nih.gov/pubmed/36824657
http://dx.doi.org/10.1016/j.bbiosy.2021.100018

Ejemplares similares